Alnylam Pharmaceuticals | ALNY - DŁUG

Cena Akcji
301.30
Dzienna Zmiana
-0.81 -0.27%
Miesięcznie
-4.68%
Rocznie
14.46%
Q2 Prognozy TE
299.00




DŁUG Zmiana Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.02B 615M 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xencor USD 69.27M 1.34M 2025-09